Introduction
Recording of consistent, dependable intracortical neural signals remains a challenge in the field of neuroprosthetics. The chronic immune response, which results in retraction of dendritic processes, neuronal cell death, and glial encapsulation [1] [2] [3] [4] [5] , remains a significant barrier despite many countermeasures that have been attempted. Strategies include direct modulation of brain's immune response and dendritic outgrowth through bioactive molecules, indirect mitigation of the immune response through novel neural probe design, and combinations of the above strategies.
Bioactive molecules have been shown to effectively attract dendritic processes closer to the probe's recording sites to improve recording quality. This has been demonstrated both by encouraging dendritic attachment to the probe [6, 7] and by suppressing the astrocytic adhesion to the probe to indirectly promote the reach of dendritic processes through the probe-bound layer of astrocytes [8] . Other approaches seek to curtail the immune response and prevent the activation of astrocytes and microglia, thereby inhibiting the formation of a glial sheath [9] [10] [11] [12] [13] .
Neural probe geometry also affects glial encapsulation and activation of the immune response. Skousen et al proposed that an open-architecture probe can reduce microglial activation and the impact of the resulting released chemical factors that promote inflammation and reduce neuronal apoptosis [14] . These results corroborate the conclusions of Seymour and Kipke that open-architecture probes can increase tissue integration, reduce adhesion of reactive cells, and improve cell-to-cell communication through increased diffusion of chemical factors in local tissue [15] .
A large body of work has been dedicated to fabricating neural probes from materials that more closely mimic the mechanical properties of brain tissue. The mechanical mismatch between conventional neural probe materials (metal microwires, silicon, and ceramic) with a Young's modulus of 100-400 GPa and brain tissue with a Young's modulus of 0.4-6 kPa [16] coupled with the micromotion arising from vascular and respiratory oscillations further aggravate the immune response and lead to chronic inflammation [3, [17] [18] [19] [20] [21] . To address these concerns, neural probes based on flexible substrates with reduced Young's moduli have been developed to better match the soft mechanical properties of the brain.
Although thin film silicon has been utilized as a flexible substrate [22] , most efforts employ polymer substrates that are less susceptible to breakage, such as polyimide [23] [24] [25] , Parylene C [26] [27] [28] [29] , or SU-8 [30] . Polyimide, Parylene, and SU-8, with Young's moduli of ∼3 GPa [18, 31] , 2.7-3.7 GPa [32] , and 2 GPa [33] , respectively, provide two orders of magnitude reduction in substrate stiffness over conventional substrate materials (e.g. silicon). However, unlike polyimide and Parylene, SU-8 does not have a history of use in Food and Drug Administration approved medical implants.
The neurotrophic electrode (NE) developed by Kennedy combines an open-architecture design with the use of growth factors to actively stimulate dendritic outgrowth toward the recording sites in the probe interior [34, 35] . This combined use of bioactive molecules and novel open-architecture probe design successfully anchored the probe into the tissue and provided stable recordings for over four years in humans [36] . Nonetheless, the NE is manually fabricated from microwires and a pulled glass micropipette tip. Although a promising technology, it does not lend itself to batch manufacturing nor include a strategy to reduce the mechanical mismatch.
Previously we developed a flexible intracortical neural probe using Parylene C (hereto referred to as Parylene), a United States Pharmacopeia Class VI polymer with a long history of use in medical implants for its desirable properties, as a structural material. Only Parylene and platinum were used in the manufacture of the three-dimensional (3D) Parylene sheath electrode (PSE) via highly repeatable batch fabrication techniques. Furthermore, the NE approach to integrate bioactive coatings was adapted for the sheath to promote neuronal growth and mitigate the immune response. The potential of the PSE was initially demonstrated in a successful one month study in the rat [37] .
In this work, the PSE technology was further improved to produce the Parylene Sheath Electrode Array (PSEA) comprising a 2×2 array with 32 total electrodes (eight on each PSE). The probe tip was redesigned to minimize footprint and increase taper to facilitate implantation and attempt to minimize the immune response. Perforations through the sheath were added to provide a more open architecture facilitating cell-cell and fluid communication as well as tissue integration. Individual 1×2 arrays were assembled using a precision stacking technique to achieve 2×2 arrays and to demonstrate the possibility of achieving even larger arrays. A new coating methodology was developed to simultaneously apply a bioactive molecule cocktail to the entire surface of all probes in the array. Additionally, we investigated an alternate approach using bare, uncoated probes in a rat brain pre-treated with microinjections of a viral construct, AAV9-SynCav1, designed to promote neuronal survival and growth [38] . A new insertion shuttle was designed and fabricated that allows simultaneous placement of the four individual PSEs. Successful recording of neural signals in vivo was obtained for up to 12 months, demonstrating the scalability of this technology and the potential for tight tissue integration with Parylenebased neural probes.
Materials and methods

Design and fabrication
Each sheath of the PSEA tapered from 300 to 50 μm and contained eight platinum electrodes with an exposed area 45 μm in diameter. Four electrodes were positioned inside of the sheath and four on the periphery of the probe ( figure 1(a) ). 1×2 sheath arrays were fabricated with mirror-image layouts on wafer with the sheaths positioned 1 mm apart, center to center. The 1×2 arrays were packaged back-to-back in pairs, resulting in a 2×2 PSEA with a total of 32 electrodes ( figure 1(b) ). The probe tip geometry of the PSEA was improved based on observations from our previous study to reduce insertion trauma and inflammation [37] . As such, the tip was designed with a sharper taper to aid insertion and minimize the penetration profile. In an effort to facilitate chemical diffusion for cell-to-cell communication and to minimize probe surface area, 15 μm diameter perforations were created throughout the entire probe tip and the fabrication process [28] was revised to accommodate the patterning of these additional features.
Perforations were designed to be 15 μm in diameter and spaced at least 10 μm from each other in order to maintain the structural integrity of the Parylene sheath while providing sufficient clearance for dendritic processes to pass through. Eighty perforations were made on each probe, positioned along the bottommost 800 μm of the probe both within the sheath periphery (16 perforations) and within the sheath structure (54 perforations), as seen in figure 1(a) .
A brief summary of the modified fabrication process for including perforations is as follows. The PSEA was fabricated through surface micromachining of Parylene and thin film platinum. Platinum was chosen for electrode sites and traces as it is an inert, biocompatible metal commonly used for neural interfaces. To begin, a 5 μm layer of Parylene was deposited on a silicon carrier wafer with its native oxide intact through a room-temperature chemical vapor deposition process. Photoresist was applied in preparation for metal lift-off, thin film platinum for electrode sites and traces was electron beam deposited, and metal patterns were revealed by lift-off in acetone followed by successive rinses in isopropyl alcohol and deionized water. A 2 μm Parylene insulation layer was deposited over the metal layer ( figure 2(a) ) and electrode sites, contact pads, and perforations in the substrate were exposed using oxygen plasma reactive ion etching ( figure 2(b) ). A photoresist sacrificial structure was patterned (figure 2(c)) and coated with a 5 μm Parylene layer to form a trapezoidal microchannel. Once more, electrode sites, contact pads, and perforations were re-exposed using oxygen plasma reactive ion etching ( figure 2(d) ). At the same time, access ports on both ends of the microchannel were also etched. Finally, the outline of the 1×2 arrays was etched out and arrays were released from the carrier wafer. The sacrificial photoresist in the microchannel was removed through an acetone soak (figure 2(e)) and the PSEAs were rinsed in acetone, isopropyl alcohol, and deionized water before they were left to air dry.
To create the final 3D sheath structure from the microchannel ( figure 3(a) ), a thermal molding process was used to impart the shape change. A custom-tapered stainless steel microwire was manually inserted into the 300 μm access port, temporarily opening the sheath into a conical shape ( figure 3(b) ). With the microwire in place, the assembly was heated to 200°C in a vacuum oven for 48 h and then slowly cooled back to room temperature to induce the shape change from a flat to a 3D sheath without thermal oxidation. The microwire was then removed ( figure 3(c) ).
Packaging
Once thermoforming was complete, the 1×2 arrays were connected to a flexible printed circuit (FPC) with a 16-channel zero-insertion-force (ZIF) connector. A polyetheretherketone (PEEK) backing was applied to the contact pad area of the array to provide the necessary stiffness and thickness to insert the 1×2 arrays into the ZIF and engage the closing latch. Two 1×2 arrays were connected back-toback onto a single double-sided FPC to create a 2×2 PSEA (figure 4). A BM10 connector (Hirose Electric Co., Ltd, Tokyo, Japan) was used to connect the PSEA to an adapter (figure 5) for reversible connections to the Omnetics connector on the data acquisition system (OmniPlex; Plexon Inc., Dallas, TX). ) [39, 40] . Each electrode was then analyzed with electrochemical impedance spectroscopy (EIS) to ensure appropriate electrode surface properties and EC behavior (37°C 1× phosphate buffered saline (PBS), 10 mV rms , 1-100 000 Hz).
2.3.2. Insertion testing. Parylene's flexibility is an advantage for reducing mechanical mismatch with tissue, but it is challenging to insert the probe into cortical tissue. Insertion shuttles or other methods to temporarily provide the required stiffness to insert the probe into cortical tissue have been explored but typically for single probes [25, 37, 41, 42] . We developed a new insertion shuttle to precisely position all four Optical micrographs and schematics depicting the thermoforming process. Sheath structures are flat as fabricated on the wafer (a). A custom-tapered microwire is inserted into the sheath, mechanically opening it and serving as a mold for the thermoforming (b). Following annealing, the microwire is removed and the sheath retains its shape (c). Scale bar=100 μm. probes of the PSEA into cortical tissue simultaneously, building upon our previous insertion shuttle for placing two probes at once [37] . Two pairs of blunt-tipped tungsten microwires (300 μm diameter, MicroProbes for Life Sciences, Gaithersburg, MD) were affixed side-by-side onto laserengraved grooves on an acrylic shuttle with superglue and positioned to create a 2×2 array spanning a 1 mm×1 mm square to target the rat M1 motor cortex. This ensured proper spacing of the four sheaths as each sheath on the 1×2 arrays was affixed to one of these microwires prior to insertion. An additional microwire (150 μm diameter) served as a fiduciary depth guide during the automated insertion process.
The PSEA was temporarily attached to the insertion shuttle with a small quantity of polyethylene glycol (PEG 3000, Sigma Aldrich, St. Louis, MO), a biodegradable material commonly used for medical applications, in two steps. In the first, the arm of the FPC of the PSEA was attached to the acrylic shuttle using molten PEG 3000 and was aligned so that the four sheaths were in line with the microwires. Following attachment of the FPC of the PSEA on the shuttle, the sheaths were mounted onto the microwires using molten PEG 3000 such that the microwires were positioned directly behind the sheaths. This is in contrast to our earlier approach in which sharp microwires were adhered with PEG to the backside of probes [37] . The stiffness of the thermoformed sheaths was leveraged to penetrate the tissue with the microwires serving as pushrods. In this way, the penetration profile of the insertion shuttle, and thus trauma to the neural tissue, was minimized. The sheaths were attached two at a time so that one 1×2 array would be affixed first, and then the tool would be flipped over and the 1×2 array on the backside of the FPC would be attached to complete a 2×2 orientation of the sheaths (figure 6).
Insertion testing of the PSEA was conducted in a brain phantom model of 0.5% agarose (A9539-50G; SigmaAldrich, St. Louis, MO), which closely imitates the mechanical properties of cortical tissue [43, 44] . Once the insertion shuttle and PSEA were positioned with the fiduciary depth guide, a linear motor (Thor Labs, Inc., Newton, NJ) inserted the PSEA at a speed of 0.8 mm s −1 . PBS was then applied to aid in dissolution of the PEG. After 5 min, the shuttle was withdrawn leaving the PSEA in the brain phantom.
Bioactive interventions
2.4.1. Coating of the PSEA with bioactive molecules. To coat the PSEA, a cocktail of bioactive molecules was combined to improve the chronic signal-to-noise ratio and increase the lifetime of the implant. Matrigel (MG) (BD Biosciences, San Jose, CA) was chosen as a basement matrix as it supports neuronal growth, attachment, and differentiation [45, 46] . This matrix was then loaded with two different growth factors to further promote neuronal growth and differentiation and one immunosuppressant to mitigate the brain's immune response. Nerve growth factor (NGF) and brain derived growth factor (BDNF) have been shown to support neuronal growth and have been incorporated into neural probes to guide neurons to electrodes [47] [48] [49] [50] . Dexamethasone (DEX) is an anti-inflammatory and immunosuppressant glucocorticoid steroid developed in the late 1950s [51, 52] that has been incorporated into neural probe implantations to reduce the immune response of the cortex [13, [53] [54] [55] [56] [57] . In this study, the coating consisted of a 3:1 ratio by volume of MG to PBS. The coating contained 1 μg ml −1 of NGF, 10 μg ml −1 of BDNF, and 1.6 mg ml −1 of DEX. To isolate the influences of the MG alone and the additional factors, devices were implanted either with no coating (control), with only the MG coating (Matrigel), or with the MG coating loaded with NGF, BDNF, and DEX (Matrigel+).
The hydrophobic nature of Parylene hinders the application of these water-soluble bioactive molecules. Several methods were investigated to facilitate the application of bioactive coatings and the most effective technique involved the use of poly-D-lysine (P6407, Sigma Aldrich, St. Louis, Figure 5 . The fully packaged 2×2 PSEA connects to an adapter with a BM10 connector to interface with the data acquisition system through an Omnetics connector. Scale bar=1 cm. Image of a 2×2 PSEA temporarily affixed to the insertion shuttle. The inset shows a schematic depicting how each sheath of the PSEA is attached to a tungsten microwire pushrod using PEG 3000. Scale bar=5 mm. MO) to alter the surface energy of the Parylene, making it more hydrophilic to allow for coating with bioactive molecules. To apply the poly-D-lysine, the PSEA was first briefly immersed into 70% ethanol and then into a 100 μl ml −1 solution of poly-D-lysine for 1 h at 4°C. The PSEA was then rinsed with triple distilled water and dried at room temperature. To apply the coating mixture, the poly-Dlysine-coated PSEA was incubated in a droplet of the coating mixture at 50°C for 5 min. The PSEA was then removed from the coating mixture and the coating was dehydrated for an additional 5 min at 50°C. ) construct was previously shown to improve neuronal survival and growth in vitro by enhancing neuronal membrane/lipid raft formation, increasing expression of neurotransmitter receptors, and promoting neuronal arborization [38] .
Ethylene oxide sterilization
Prior to implantation, the PSEA was PEG-attached onto an insertion shuttle and the insertion shuttle was then mounted on a custom probe holder (metal shaft with a plastic block at the bottom). The entire assembly was then sterilized with ethylene oxide for 24 h using a room-temperature system (Anprolene AN74i, Andersen Products, Haw River, NC). After sterilization, probes were stored at 4°C prior to implantation (∼1-2 d). The EC effects of the sterilization process was investigated in a separate study and found to be negligible [58] . However, the sterilization process was found to degrade a portion of the factors across all samples (approximately 13%, 37%, and 47% degradation for DEX, BDNF, and NGF, respectively), as observed through enzymelinked immunosorbent assay (ELISA), likely due to the amount of time spent in a dry environment at room temperature [59] . The chronic implantation surgery was performed in the rat M1 motor cortex of young male Sprague Dawley rats (>320 g) as follows. Anesthesia was induced by placing the rat in a chamber filled with 4% isoflurane in 1 Lpm oxygen.
The animal was then placed in a stereotaxic frame (Small animal stereotaxis; Kopf Instruments, Tujunga, CA) and 1%-3% isoflurane in 1 Lpm oxygen was administered via a nose cone. Following a 2 cm long midline incision and retraction of the skin, six holes were drilled into the skull to allow for attachment of a titanium headplate (used as reference/ground) with six stainless steel screws. A craniotomy was made centered at +1.5 mm AP and 1.5 mm ML from bregma, exposing the M1 cortex. The dural membrane over the target area was incised and retracted. The PSEA/insertion shuttle assembly mounted on the probe holder was positioned over the opening area using a stereotaxic apparatus and with the help of the fiduciary depth guide protruding from the insertion shuttle. The assembly was then inserted through the pia and 2 mm into the cortex with a motorized drive (microsyringe pump UltraMicroPump UMP3, WPI) at a speed of 0.8 mm s . Following insertion, bone cement was applied to the skull below the lateral portion of the PSEA to anchor the PSEA in place. After allowing five minutes for the bone cement to cure, saline was applied to allow for PEG dissolution and separation of the PSEA from the insertion shuttle, and the shuttle was withdrawn. Gelfoam was applied to cover the craniotomy and additional bone cement was applied over Gelfoam and surrounding skull to create the head cap around the PSEA and connector, securing the FPC to the headplate and skull. The skin was then sutured around the head cap (4-0 nylon monofilament sutures; Keebomed Inc., Morton Grove, IL). The animal was kept on a warming pad in a recovery cage until it was fully awake and sternal, at which point the animal was returned to its housing cage.
In the Caveolin-1 group, we performed microinjections of the viral construct, AAV9-SynCav1, in the M1 cortex. Microinjections were done at 9 cortical sites spaced 0.5 mm apart rostro-caudally and medio-laterally with a 35-gauge needle (OD 135 μm) mounted on a 10 μl microsyringe pump (UltraMicroPump UMP3, WPI) inserted to a depth of 1.7 mm using a three-dimensional precision micromanipulator. At each cortical site, a 1 μl volume of AAV9-SynCav1 was slowly injected at a speed of 0.5 μl min -1 ; the needle was left in place for additional 2 min before retraction to prevent backflow. The PSEA was then inserted into the same cortical area immediately following the viral injections. 
In vivo testing
To assess the functionality of PSEA, in vivo EIS and neural recordings were carried out weekly (starting at week 1) or biweekly (starting on week 30) and ending at or shortly before animal's sacrifice time (week 14-52 post-implantation). During testing, the rats were anesthetized with ketamine/xylazine (90/10 mg kg −1 , IP).
EIS recordings
In vivo EIS measurements were obtained using a PC4/300 potentiostat system (Gamry Instruments, Warminster, PA) in a two-electrode configuration, with the reference and counter connected to the titanium headplate. The data were collected with 10 mV rms sinusoids at frequencies from 1 Hz to 100 kHz.
The impedance values at 1 kHz were selected for analysis due to the correspondence of this frequency to the bandwidth of neural signals in the brain.
Electrophysiology recordings
Electrophysiological data were acquired at 16 bit and 40 kHz per channel using a 64-channel data acquisition system (OmniPlex; Plexon Inc., Dallas, TX) and high-pass filtered at 300 Hz to remove the low-frequency fluctuations from the baseline.
Spike detection, determination of SNR
The collected data were used to calculate three performance metrics: unresolved neural noise, signal-to-noise ratio (SNR), and firing rate. In the 120 s (sec) data records, spike detection was performed using the nonlinear energy operator (NEO) method, which allows more accurate spike detection at low SNRs as compared to a more commonly used amplitude thresholding method [60] . The neuronal noise was calculated as the standard deviation of the data after removal of 0.8 mslong segments containing the detected spikes. The spike amplitude was calculated as the absolute value of spike's peak height. The average spike amplitude for the record was calculated using all detected spikes. Spike sorting was not applied to remove false positives, as the data was collected while the rats, along with the connected headstage and preamplifier, were placed in a Faradaic cage, eliminating externally generated electromagnetic interference at the Hz-kHz frequency range. Furthermore, there were no electromyographic artifacts, as the ketamine/xylazine anesthesia was sufficiently deep to suppress animal movements. Since both the average spike amplitude and average noise were calculated as monophasic values (as opposed to the biphasic peakto-peak amplitude calculation), the SNR was calculated simply as the ratio of these values. The firing rate was also calculated for all spike-like events. The SNR and firing rate values were calculated for a record only if 10 or more spikelike events were detected in 120 s.
Histology
Within an hour after the last electrophysiological test, the rats were injected with heparin sulfate (1000 IU/kg, IP), while still anesthetized with ketamine/xylazine (90/10 mg kg −1 , IP), and transcardially perfused with 100 ml of a pre-wash containing PBS with heparin (5 IU ml -1 ) followed by 200 ml of phosphate buffered 4% paraformaldehyde solution. The head was removed and immersion-fixed in 4% paraformaldehyde overnight. The next day, cerebral cortex dissection was performed. An effort was made to keep the probe inside the cortex during the removal of the bone cementencapsulated PSEA. In several cases, however, the probe came out from the cortex due to insufficient connective tissue encapsulation to hold it in place. The cortical tissue block containing the probe tracks (and the probes, if still in place) was embedded into paraffin. The tissue was sectioned at a thickness of 10 μm in a direction perpendicular to the probe tracks. The sections were then double-immunostained for GFAP (marker for reactive astrocytic processes) and for NeuN (neuronal marker). The primary antibodies were antiNeuN (MAB377, 1:2000, Chemicon, Temecula, CA) and anti-GFAP (Z0334, 1:10 000, Dako Corp., Carpinteria, CA), and the chromogens were Vector nickel-DAB (for NeuN) and Vector Red (for GFAP). Tissue sections were photographed using a color CCD microscope camera (Grasshopper Express 2.8 MP, Point Grey Research). adsorption/desorption of hydrogen, which is expected for a platinum electrode surface in H 2 SO 4 ( figure 7) .
Results
Following EC cleaning, EIS measurements indicated consistent performance across devices with very little variability amongst devices from the same wafer as well as between wafers, as seen in figure 8 . It was previously determined that the coating process changed the EIS of an uncoated probe with a slight increase in impedance [59] . Due to the water-soluble nature of the coatings, EIS of each PSEA electrode was conducted only prior to coating. At 1 kHz, average electrode impedance was found to be 226.7±28.4 kΩ (mean±SE, n=715 electrodes across 94 sheaths), which is appropriate for intracortical recording applications [61] .
Insertion testing.
Insertion testing conducted in agarose showed successful insertion of the PSEA sheaths. However, it was previously observed that the sheaths retracted 86.3±36.0 μm (mean±SD, n=6 trials) when the shuttle was withdrawn [37] . This was attributed to surface tension between the microwires on the insertion shuttle and the PSEA from the saline and dissolved PEG. To compensate, a deeper insertion was required so that the expected retraction in vivo resulted in placement of the PSEA in the desired location.
4.2. In vivo study 4.2.1. Implantation. In comparison with our initial onemonth study [37] , we made several improvements to the implantation technique. First, we adopted the pushrod insertion shuttle, which was simple to use and produced less displacement of cortical tissue during the insertion than our earlier methods. Minimizing displacement was essential given the small target volume and the increased number of probes (from 2 to 4). Second, we used a motorized drive, which improved the consistency of speed and depth penetration, which was important given the quick dissolution of PEG in the tissue. Third, the craniotomy was covered with Gelfoam instead of Kwik-Sil silicone for protecting the cortex from bone cement. Kwik-Sil adheres to both the probe and the overlaying bone cement, thus the probes often pulled out while removing the cemented headcap. In addition, Gelfoam (unlike the Kwik-Sil) degrades soon after implantation and is replaced with a layer of loosely organized connective tissue, which provides strain relief between the probes and the cable and provides the access to the PSEA cable during the dissection for separating the probes from the rest of the assembly and headcap. Just as in our initial one-month study, a titanium headplate was screwed into the skull surrounding the craniotomy and the FPC was affixed to the skull and secured head plate with bone cement, keeping the BM10 connector exposed for connection, as seen in the last frame of figure 9.
EIS and electrophysiology.
Neural recordings were collected weekly (in a few animals surviving beyond week 30, the recordings were then done biweekly) and the spikes were detected using the NEO thresholding method, as described in the methods. Detected spikes from a representative electrode in a long-surviving animal from the Caveolin-1 group are shown in figure 10 .
Comparison of electrochemical and electrophysiological performance at 10-14 weeks (figure 11) indicated that the control uncoated group had a significantly lower electrochemical impedance and smaller SNR compared to the other groups. This suggests that Matrigel-containing coatings and virally mediated Caveolin-1 expression had a beneficial effect on probe integration with the tissue and on the electrophysiological performance. The best electrophysiological performance, in terms of firing rate and SNR, was exhibited by the Matrigel+ and Caveolin-1 groups. Although the electrode impedance, noise level, and SNR were comparable between the Matrigel and Matrigel+ groups, the increased firing rate observed in the Matrigel+ group indicates that the included NGF, BDNF, and DEX had a positive impact on neuronal activity despite any degradation that may have occurred during the sterilization process.
Temporal dynamics of the electrochemical and electrophysiological performance were evaluated for the 22-weeklong post-implantation period, as the animals from multiple groups were sacrificed at that time point (animals in the Matrigel+ group were sacrificed earlier at 14 weeks) ( figure 12 ). Temporal dynamics of 1 kHz impedance measurements indicated their initial rise and delayed decrease ( figure 12(a) ). The initial rise was likely caused by the electrode encapsulation, while the delayed decrease could have been caused either by a degradation of the PSEA probe insulation or by a chronic glial response at the electrode-tissue interface. The noise level increased in the first 4-6 weeks and then remained relatively constant in all groups ( figure 12(c) ). Resolvable multiunit neural activity was not detected (and, therefore, SNR was not calculated) during week 1, first appeared at week 2 and then gradually increased over the course of 12-14 weeks and reached a plateau of performance ( figures 12(b) and (d) ).
Detailed examination of electrophysiological performance in two long-surviving animals-first from the Caveolin-1 group (figure 13) and second from the Matrigel group ( figure 14) -demonstrated considerable variability among four probes implanted side-by-side over the 52-week post-implantation period. The best performing 8-electrode PSEA probe (#1) in the Caveolin-1 animal exhibited a remarkable gradual improvement in the firing rate despite the stable levels of impedance, noise, and SNR, suggesting plastic changes in the neuronal activity levels, perhaps indicative of a continued virally mediated Caveolin-1 expression in the cells ( figure 13 ). In the animal from the Matrigel group, the noise level in probe #1 was considerably higher, while the firing rate and SNR performance were similar in probes #1 and #2 (figure 14).
Immunohistochemistry
Immunohistochemical evaluation was performed on the cortical tissue from two long-surviving animals-first from the Caveolin-1 group (figure 15) and second from the Matrigel group (figure 16)-in order to examine whether the local tissue environment surrounding the probes contributed to their variable electrophysiological performance within the same PSEA (figures 13 and 14). As can be seen in both animals, there was significant variability in the density of NeuN-stained neurons and GFAP-positive reactive astrocytosis in the cortical tissue around each of four probes.
In the Caveolin-1 animal (figure 15), probes #1 and #2 exhibited a closer apposition of neurons to the probe's surface and lower density of reactive astrocytosis (as compared to probes #3 and #4), which correlates with the detection of resolvable neural activity by these probes ( figure 13 ). In the same animal, NeuN staining was also apparent inside the probe #1, which correlates with a higher SNR and firing rate in that probe as compared to probe #2, suggesting sprouting of dendrites through the perforations.
In the Matrigel animal ( figure 16 ), probes #1 and #2 also exhibited a closer apposition of neurons to the probe's surface and lower density of reactive astrocytosis (as compared to probes #3 and #4), which correlates with the detection of resolvable neural activity by these probes ( figure 14) . No NeuN staining was apparent inside these probes (with a caveat that some of the tissue inside the lumen was detached during the slide staining process), correlating with their low SNRs and firing rates (as compared to the probe #1 in the Caveolin-1 animal).
Finally, we have compared the changes in neural signals (i.e. amplitudes of resolvable action potentials) at 3 weeks versus the last pre-sacrifice time point, and observed similar increases in the signals in both long-surviving animals ( figure 17) . In both the Matrigel and the Caveolin-1 animal, there was a slight, but statistically insignificant, signal increase for the electrode sites located inside the probe sheath as compared to those outside the sheath. This is in sharp contrast with our previous study in which, at 28 weeks, a higher SNR was observed from the outer rather than the inner electrodes of Matrigel-coated probes [37] . 
Discussion
A 3D Parylene intracortical neural probe array was designed, fabricated, characterized, and successfully implanted into the rat motor cortex for 12 months. 32 electrodes distributed across four 3D sheath structures allowed for a higher electrode count and density to interface with more neurons and improved recording quality than with the 1×2 array design utilized in our previous one-month study. Moreover, this design is highly scalable with minimal modifications as multiple arrays containing any number of probes each can be combined on an FPC in a similar fashion as demonstrated here. For example, the 1×2 arrays can easily be made into 1×4 or 1×8 arrays by adjusting the layout. These can then be stacked using the technique developed here into 4×4 or 8×8 arrays. The only practical limitation is the available channel count in commercially available ZIF connectors. Microfabricated entirely from Parylene and platinum materials, the PSEA utilized the flexibility of Parylene to minimize inflammatory response in the surrounding tissue. The sheath structures featured a sharp taper in order to reduce damage to tissue during insertion, based on the taper optimization performed in the previous study [37] . Additionally, perforations were placed throughout the sheath to improve chemical signaling between cells and to promote dendritic sprouting. The EC properties of the electrodes were evaluated in vitro and found to be appropriate for neuronal recording. Additionally, very little variability was observed over 766 electrodes from 96 different sheath structures, indicating a very consistent fabrication and electrode cleaning process. Prior to implantation, the PSEA was coated with Matrigel loaded with NGF, BDNF, and DEX to encourage neural integration and to suppress the immune response. The hydrophobic nature of Parylene was concealed through the use of poly-D-lysine, which uniformly coated all PSEA surfaces, including the sheath interior. A custom insertion shuttle was developed to temporarily provide the necessary stiffness for inserting the PSEA into cortical tissue and then to retract, leaving only the compliant PSEA in the tissue.
Longitudinal electrophysiological measurements revealed improved SNR at probes with bioactive interventions as compared with the control. Although the Matrigel coating exhibited a higher SNR than the uncoated control, it exhibited very similar firing rates. However, the inclusion of NGF, BDNF, and DEX into the Matrigel coating (Matrigel+) was shown to improve neuronal firing rate over the use of a Matrigel coating alone, suggesting that they provide additional support to neuronal health. These results and previous work which has shown that these factors elute from the coating within a short time course [59] suggest that an even greater impact may be achieved through the use of a prolonged release profile or repeated application. However, novel delivery mechanisms would have to be developed and additional studies conducted to investigate that possibility. In the current study, the best performance was observed in probes at which virally mediated Caveolin-1 was expressed, indicating a superior biological environment for probe integration into tissue.
Immunohistochemical analysis of cortical tissue indicated significant variability in the density of NeuN-stained neurons and GFAP-positive reactive astrocytosis around individual probes, even on a single array within the same animal. Closer apposition of neurons to the PSEA surface (probes #1 and #2 versus probes #3 and #4 in the Caveolin-1 and Matrigel animals) was correlated with the ability to detect resolvable neural activity by these probes. Furthermore, presence of NeuN staining inside the probe #1 in the Caveolin-1 animal was correlated with the highest SNR and firing rate for the electrode sites in that probe (as compared to other probes in that animal and other animals in the study), suggesting that a virally mediated long-term expression of Caveolin-1 may have contributed to dendritic sprouting and was manifested as a gradual increase in the SNR during the first 15 weeks post-implantation and even more protracted rise in the firing rate. To our knowledge, this represents the first example in the literature of a direct correlation between the gradual rise in the neural signaling and histologically observable dendritic sprouting. An alternative explanation for the rise in SNR would be due to deterioration in the Parylene coating of the PSEA, but that explanation is unlikely given the stability of electrical impedance and noise level during that period.
As compared to our earlier one-month study with manually inserted PSEAs [37] , in this study we observed less GFAP-positive reactive astrocytosis around the probes. The reduced level of astrocytosis can be attributed to a smaller tissue displacement exhibited by the pushrod insertion shuttle, as compared to the earlier insertion shuttle designs, and the inclusion of perforations throughout the probe structure that enabled cell-to-cell chemical signaling. In contrast with our one-month study, we demonstrated a comparable or slightly greater increase over time for the amplitude of neural signals for the inner electrode sites as compared to the outer ones in the Matrigel and Caveolin-1 groups. We speculate that Caveolin-1-mediated neurotropic signaling and the supportive biological environment created by Matrigel in combination with the probe perforations and the acellular tissue structure inside the probe sheath provided an attractive environment for dendritic sprouting through perforations into the sheath. In comparison, dendritic sprouting outside the probe was possibly constrained by a presence of a dense astrocytic layer around the probes. Further studies are needed to explore this possibility.
Overall, this study provided support for the importance of creating a supportive biological environment around neural probes to promote stable long-term electrophysiological performance of flexible probes in the cerebral cortex. In particular, we demonstrated the beneficial effects of a Matrigel coating, the inclusion of additional neurotrophins and immunosuppressants into that coating, and the long-term expression of Caveolin-1. Furthermore, we provided support to the idea of using an artificial acellular tissue compartment as a way to counteract the walling-off effect of the astrocytic scar formation around the probes as a means of establishing a more intimate and stable neural interface.
